Photo: Jakub Żerdzicki / Unsplash
Documents obtained by STAT and The New York Times show every task force member was cleared to serve despite financial ties to the care they rate.
Background
The U.S. Preventive Services Task Force is a 16-member panel whose recommendations decide which preventive services, such as screening colonoscopies and HIV-prevention drugs, most insurers must cover [3]. A 2025 Supreme Court decision in Kennedy v. Braidwood Management held that the panel operates under the health secretary's authority, which underpins Health and Human Services Secretary Robert F. Kennedy Jr.'s power to remove and appoint its members [3].
Kennedy has used that power. He removed the panel's two vice chairs in May, and on Sept. 17 he named eight new members, five of them medical specialists rather than the generalist clinicians who have traditionally filled the seats [3]. The American Medical Association called the specialist-heavy roster a "significant departure from the Task Force's traditional membership" [3]. Eight members appointed under President Biden remain [3].
What the Filings Show
On Nov. 11, STAT reported that federal officials had granted blanket ethics waivers to every member of the task force, allowing them to serve even though some have financial stakes in decisions the panel may make [1]. STAT obtained the waivers, which it said were signed by a top federal official [1].
According to STAT, the waived conflicts include stock in pharmaceutical and medical device companies and employment at public research universities that provide medical care [1]. Two members own private medical practices that could profit if the panel recommends particular types of care, STAT reported [1]. Some members, particularly the newer appointees, have more extensive conflicts than others [1]. The portion of STAT's report available to non-subscribers does not name the two practice owners, and VBN has not identified them.
STAT's findings followed a Nov. 5 New York Times report, based on waivers obtained through a public records request, that four of the eight September appointees hold stock in drugmakers and other companies affected by the panel's decisions [2]. According to coverage of that report, the four are pediatrician Patrick K. Hunter, cardiologists Ronald P. Karlsberg and Venkatesh L. Murthy, and diagnostic radiologist Dennis W. Wulfeck [2]. All four hold shares in Eli Lilly and Johnson & Johnson; other holdings among the group include Bristol Myers Squibb, Merck, Pfizer, Novo Nordisk, CVS Health and Cigna [2].
Wulfeck's waiver lists Eli Lilly, Johnson & Johnson, Novo Nordisk, Pfizer and CVS Health plus 17 other companies [4]. Roger D. Klein, director of the Agency for Healthcare Research and Quality (AHRQ), wrote in the waivers that the relevant companies make up between 15% and 45% of the members' portfolios, and that no single member can make a final decision on behalf of the government [2]. The waivers still require members to consider whether to step aside from topics tied to their financial interests [4]. No dollar values for the holdings have been reported in the coverage VBN reviewed.
Holding stock or owning a practice is a potential conflict of interest, not evidence of wrongdoing, and none of the reports allege that any member has acted improperly. For a department whose secretary often criticizes corporate influence in medicine, the waivers show a willingness to overlook such ties, STAT wrote [1]. Critics may also notice that the portfolios look rather more diversified than the rhetoric.
The Response
HHS spokesperson Emily Hilliard told the Times that the Supreme Court ruling made task force members special government employees, who fall under different ethics rules, and that AHRQ is updating its procedures to match [2]. Wulfeck declined to comment on his investments; the other three members named by the Times did not respond to it [2].
Former officials see it differently. Quyen Ngo-Metzger, who reviewed task force conflicts at AHRQ from 2012 to 2019, said candidates previously had to sell such holdings before appointment [2]. Industry involvement "undermines the trust in the process," she told the Times [2]. Former task force officials also warned that the conflicts could weaken confidence in recommendations that shape insurance coverage, including for mammography [4].
What Comes Next
On Nov. 13, Sens. Angus King (I-Maine) and Elizabeth Warren (D-Mass.) introduced a bill that would write membership and conflict-of-interest standards for the task force into law [5]. The waivers leave members on the panel but could still require them to recuse themselves from specific matters [5]. HHS has not said when AHRQ's revised ethics procedures will be finished, and the task force's public conflict-of-interest disclosure page says it is under review and being updated [6].
This article is for informational purposes only and is not medical advice; readers with health questions should consult their clinician.
References
Cirruzzo C. Doctors on Kennedy's influential preventive care panel have major conflicts of interest, filings reveal. STAT. Nov 11, 2026. https://www.statnews.com/2026/11/11/kennedy-hhs-preventive-care-panel-conflict-interest-waivers/
Mathewes F. Half of RFK Jr.'s new USPSTF picks hold drugmaker stocks: NYT. Becker's ASC Review. Nov 6, 2026. https://www.beckersasc.com/asc-news/half-of-rfk-jr-s-new-uspstf-picks-hold-drugmaker-stocks-nyt/
Cirruzzo C, Cooney E, Todd S. Kennedy moves to revive preventive services panel with new members, after months of vacancies. STAT. Sep 17, 2026. https://statnews.com/2026/09/17/kennedy-names-eight-new-members-uspstf-task-force
AuntMinnie.com staff. Report: USPSTF radiologist among appointees holding healthcare stocks. AuntMinnie.com. Nov 6, 2026. https://www.auntminnie.com/industry-news/regulatory/news/16424523/report-uspstf-radiologist-among-appointees-holding-healthcare-stocks
Cirruzzo C. Senators introduce bill to curb conflicts of interest on preventive care panel. STAT. Nov 13, 2026. https://www.statnews.com/?p=1547745
U.S. Preventive Services Task Force. Conflict of Interest Disclosures. Accessed Nov 19, 2026. https://www.uspreventiveservicestaskforce.org/uspstf/index.php/node/47